Valuation: Mankind Pharma Limited

Capitalization 94TCr 1.09TCr 947.11Cr 892.89Cr 811.84Cr 1.5TCr 1.69TCr 11TCr 4.05TCr 43TCr 4.1TCr 4.01TCr 1,59400Cr P/E ratio 2025
49.3x
P/E ratio 2026 * 45.2x
Enterprise value 1,01200Cr 1.17TCr 1.01TCr 956.44Cr 869.62Cr 1.61TCr 1.81TCr 11TCr 4.33TCr 46TCr 4.39TCr 4.29TCr 1,70800Cr EV / Sales 2025
8.71x
EV / Sales 2026 * 6.71x
Free-Float
22.83%
Yield 2025 *
0.39%
Yield 2026 * 0.34%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.57%
1 week-3.88%
Current month-7.25%
1 month-9.58%
3 months-5.23%
6 months-18.41%
Current year-20.54%
More quotes
1 week 2,284
Extreme 2284
2,383.7
1 month 2,284
Extreme 2284
2,548
Current year 2,115.1
Extreme 2115.1
2,998.4
1 year 1,901.05
Extreme 1901.05
3,054.8
3 years 1,242
Extreme 1242
3,054.8
5 years 1,242
Extreme 1242
3,054.8
10 years 1,242
Extreme 1242
3,054.8
More quotes
Manager TitleAgeSince
Chief Executive Officer 49 21/09/2007
Director of Finance/CFO 56 03/03/2016
Compliance Officer 47 09/01/2025
Director TitleAgeSince
Chairman 69 03/07/1991
Director/Board Member 59 22/12/1992
Director/Board Member 49 21/09/2007
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.57%-3.88%+5.65% - 1.09TCr
-2.84%-6.91%-13.71%+148.70% 68TCr
-0.62%-4.65%+0.70%-14.77% 36TCr
-0.10%-3.02%+8.75%+25.58% 33TCr
-2.58%-7.83%-51.84%+25.00% 33TCr
-0.27%-3.86%+2.57%-13.95% 25TCr
-0.34%-2.34%+0.96%+20.36% 23TCr
-1.52%-5.41%-16.68%+2.61% 22TCr
-0.29%-3.24%-39.52%-11.33% 20TCr
-0.10%-2.00%-6.11%+20.48% 16TCr
Average -1.02%-4.14%-10.92%+22.52% 27.63TCr
Weighted average by Cap. -1.31%-4.71%-12.55%+42.01%
See all sector performances

Financials

2025 2026 *
Net sales 12TCr 142.01Cr 123.24Cr 116.18Cr 105.63Cr 195.11Cr 220.44Cr 1.38TCr 526.48Cr 5.64TCr 532.87Cr 521.44Cr 21TCr 15TCr 171.29Cr 148.65Cr 140.14Cr 127.42Cr 235.34Cr 265.89Cr 1.66TCr 635.03Cr 6.8TCr 642.74Cr 628.96Cr 25TCr
Net income 1.94TCr 22Cr 19Cr 18Cr 17Cr 31Cr 35Cr 217.07Cr 83Cr 889.7Cr 84Cr 82Cr 3.27TCr 2.1TCr 24Cr 21Cr 20Cr 18Cr 33Cr 38Cr 235.23Cr 90Cr 964.11Cr 91Cr 89Cr 3.55TCr
Net Debt 6.72TCr 78Cr 67Cr 64Cr 58Cr 106.72Cr 120.58Cr 752.7Cr 287.97Cr 3.09TCr 291.47Cr 285.22Cr 11TCr 5.07TCr 59Cr 51Cr 48Cr 44Cr 80Cr 91Cr 567.45Cr 217.1Cr 2.33TCr 219.74Cr 215.02Cr 8.55TCr
More financial data * Estimated data
Logo Mankind Pharma Limited
Mankind Pharma Limited is an India-based pharmaceutical company. It is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It offers healthcare solutions for a range of healthcare needs with a portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/ central nervous system, vitamins, minerals and nutrients and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. Its branded product portfolio spans women’s health, fertility and critical care, with several brands in their respective therapy areas. Its subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Jaspack Industries Private Limited, and others.
Employees
19,540
More about the company
Date Price Change Volume
20/25/20 2,288.80 -1.57% 12,23,889
19/25/19 2,325.20 -1.40% 1,80,419
18/25/18 2,358.30 +0.22% 4,15,934
17/25/17 2,353.20 -0.71% 2,09,312
16/25/16 2,370.00 -0.47% 2,51,064

Delayed Quote NSE India S.E., June 20, 2025 at 05:19 pm IST

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
2,288.80INR
Average target price
2,712.47INR
Spread / Average Target
+18.51%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MANKIND Stock